Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, discussed the primary findings of their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health, focusing on patient and provider experiences.
Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey discussed the primary findings of their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health. In response to the COVID-19 pandemic, the program was created to promote home infusion of oncology therapeutics instead of receiving them at an oncology infusion center.
Jan went into more depth about the program and its findings during the AMCP Nexus session, "Implementation of a Novel Oncology Home Infusion Model" on October 18. At Horizon Blue Cross Blue Shield of New Jersey, she is the vice president and chief pharmacy officer. Jan is also professor emerita at Rutgers University's Ernest Mario School of Pharmacy.
Transcript
What were the primary findings of the pilot program, especially in terms of patient and provider experience?
It is one thing to say we are improving the delivery and making it accessible for the members to get it at home, but what is the member experience? What is the provider experience? We have gotten really good feedback from the members. The most positive experiences and testimonials have come from the members because they really liked the convenience of being at home. Even if they have side effects after the chemotherapy, they are at home, they are comfortable, they have a lot of access to the nurses, and, even through FaceTime, the providers—so they could talk—they could have that engagement with them, even after the infusion nurse had left the house.
Secondly, from a hospital perspective, this actually was very helpful from a provider perspective because what they did was that they backfilled those chairs with other infusions; they had limited capacity. So, now, when you move these infusions to home, those chairs then were utilized for other infusions that the hospital did not have enough chairs for, so that was a win for all of the stakeholders that were involved in this. The providers, initially, were a little skeptical, and we had the leadership really talk to them and say, "These are the drugs that the patient will be infused with at home, let us know if you have any concerns." Once they started doing it, their comfort level improved over time. Now, without thinking, they would refer the patients.
We also had a process developed as we started doing this intake and moving patients to home that we had to actually hide in the hospital setting a couple of technicians who could do the the process of identification and going through all the paperwork and everything else. That was something that was an operational enhancement in that original process, but that took away a lot of work burden from the hospital. Some of these infusions and chemotherapies could be 5 hours, 6 hours, 2 hours. If you take that time out of the resources at the hospital where we now have nursing shortages; during COVID-19, it was worse, but it still has not gone back to normal. Giving that [infusion] at a patient's home gave them [nurses] more resources to attend to other patients. Now, as the COVID-19 has subsided, going forward, it is something that is really being triggered by convenience, triggered by the fact that it is very convenient for the member to get it at home and not travel distances to get the infusion.
The other thing that was actually very important, which was not only because of COVID-19, but we learned that a lot of patients would miss chemotherapy. If you miss a cycle, then the next cycle is postponed. So, you are really impacting the outcome of those therapies, and that was unusual circumstances, which was really enlightening for us to understand that sometimes people miss. Now, people can't miss when somebody's going to their homes and delivering the care. That was, I think, big learning that it [home infusion] is not only conducive to improve member experience, but it also helps in the outcomes of the therapy in general.
A new federal rule will enable thousands of immigrants in the Deferred Action for Childhood Arrivals (DACA) program to obtain health care through the Affordable Care Act; a forthcoming CMS rule is expected to lower home-based care wait times and raise caregiver wages; the HHS Office for Civil Rights has finalized 2 rules that strengthen the ACA’s health care discrimination ban.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
A new federal rule will enable thousands of immigrants in the Deferred Action for Childhood Arrivals (DACA) program to obtain health care through the Affordable Care Act; a forthcoming CMS rule is expected to lower home-based care wait times and raise caregiver wages; the HHS Office for Civil Rights has finalized 2 rules that strengthen the ACA’s health care discrimination ban.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
2 Commerce Drive
Cranbury, NJ 08512